Design of a phase i clinical trial to evaluate intratumoral delivery of ErbB-targeted chimeric antigen receptor T-cells in locally advanced or recurrent head and neck cancer

Human Gene Therapy Clinical Development

Volumn 24, Issue 3, 2013, Pages 134-142

  Van Schalkwyk, May C I ^a   Papa, Sophie E ^a   Jeannon, Jean Pierre ^b   Urbano, Teresa Guerrero ^b   Spicer, James F ^a   Maher, John ^a,c,d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^d KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CARCINOMA, SQUAMOUS CELL; FEMALE; GENES, ERBB; GENETIC THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOTHERAPY; MALE; RECEPTORS, ANTIGEN; RECEPTORS, CYTOKINE; RECOMBINANT PROTEINS; RESEARCH DESIGN; T-LYMPHOCYTES;

EID: 84897468319     PISSN: 23248637     EISSN: 23248645     Source Type: Journal    
DOI: 10.1089/humc.2013.144     Document Type: Article

References (45)